**RENEWED PUBLIC HEALTH EMERGENCY PROTECTIVE MEASURES**

Due to the continued transmission of COVID-19 cases in Japan, the following protective measures have been established and are mandatory for all individuals present on or assigned to Yokota Air Base. This order also includes personnel assigned to mission partner and tenant units.

Renewed PHE Protective Measures - 1 Oct 2021

 

**Updated October 1, 2021**

U.S. Forces Japan extends Japan-wide public health emergency

The commander of US Forces Japan has extended the Public Health Emergency (PHE) for Japan in accordance with DoD Instruction (DoDI) 6200.03, “Public Health Emergency Management (PHEM) Within the DoD.” The PHE will automatically terminate on 22 October 2021, unless it is renewed and republished or sooner terminated by the commander. This order supersedes the previous PHE declaration for Japan issued on 1 July 2020.

CDC - www.cdc.gov

USFJ Facebook - https://www.facebook.com/USForcesJapan/

Foreign Clearance Guide (CAC Enabled) - https://apacs.milcloud.mil/apacs/ssoservlet

Yokota Passenger Terminal Facebook - https://www.facebook.com/YokotaPassengerterminal730ams/

DoD COVID Guidance - https://www.defense.gov/Explore/Spotlight/Coronavirus/Latest-DOD-Guidance

 

COVID-19 Vaccine Distribution

** To schedule a COVID-19 vaccination appointment, visit the 374th Medical Group appointment page at: https://yokota.tricare.mil/Getting-Care/Appointments-Referrals/

U.S. Forces Japan (USFJ) is implementing the Department of Defense (DoD) COVID-19 vaccine plan centered on a standardized and coordinated strategy for prioritizing, distributing, and administering the COVID-19 vaccine. 

USFJ has implemented the DoD’s phased approach to vaccinate all Active component, Reserve component, TRICARE Prime and TRICARE Select beneficiaries, and select DoD civilians and contract personnel along with Local National employees that are not contractors authorized to receive immunizations from DoD. Please see above link to schedule an appointment to receive a vaccine.

Questions and Answers
FAQ